Omega Diagnostics Group Plc (ODX) Rating Reiterated by FinnCap
Omega Diagnostics Group Plc (LON:ODX)‘s stock had its “corporate” rating reissued by investment analysts at FinnCap in a research note issued to investors on Tuesday. They presently have a GBX 28 ($0.35) target price on the stock. FinnCap’s price objective would indicate a potential upside of 53.42% from the company’s current price.
Shares of Omega Diagnostics Group Plc (LON:ODX) opened at 18.0625 on Tuesday. The stock’s market cap is GBX 19.64 million. Omega Diagnostics Group Plc has a 52-week low of GBX 13.50 and a 52-week high of GBX 21.00. The firm’s 50-day moving average is GBX 17.37 and its 200 day moving average is GBX 17.23.
About Omega Diagnostics Group Plc
Omega Diagnostics Group PLC is a medical diagnostics company. The Company’s segments are Allergy and Autoimmune; Food Intolerance; Infectious/Other, and Corporate. Its product categories include allergy, anemia, autoimmunity, fertility and growth hormones, food intolerance, infectious disease, inflammation, quality control, thyroid hormones and tumor markers.
Receive News & Ratings for Omega Diagnostics Group Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Diagnostics Group Plc and related companies with MarketBeat.com's FREE daily email newsletter.